Pay your money, take your chance

2002 was a year of mixed fortunes for investors and issuers in the CDO market, with a slew of downgrades masking several success stories. Mark Pelham discovers whether the ‘lucky dip’ approach to CDO investment will continue this year

cdooutlook-pic-1-gif

By rights, the past year should have been a tough one for collateralised debt obligations (CDOs), but despite record downgrades and horror stories of huge corporate losses, the CDO market did, in fact, grow.

And because of improving credit conditions, the CDO market’s increasing importance and new asset and structural possibilities, bankers have high hopes that 2003 will prove at least as good as last year in terms of new issuance. Even so, as far as investors are concerned, buying CDOs remains a

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Credit risk & modelling – Special report 2021

This Risk special report provides an insight on the challenges facing banks in measuring and mitigating credit risk in the current environment, and the strategies they are deploying to adapt to a more stringent regulatory approach.

The wild world of credit models

The Covid-19 pandemic has induced a kind of schizophrenia in loan-loss models. When the pandemic hit, banks overprovisioned for credit losses on the assumption that the economy would head south. But when government stimulus packages put wads of cash in…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here